| 2024-11-19 | -0.28 % |
|
| 2024-11-15 | +1.37 % |
|
| 2024-11-12 | +0.47 % |
|
| 2024-11-11 | +0.8 % |
|
| 2024-11-08 | -0.67 % |
|
| 2024-11-07 | -1.49 % |
|
| 2024-11-04 | +1.69 % |
|
| 2024-11-01 | +1.81 % |
|
| 2024-10-31 | -0.35 % |
|
| 2024-10-29 | +0.46 % |
|
| 2024-10-28 | -0.46 % |
|
| 2024-10-23 | -0.28 % |
|
| 2024-10-18 | +1.37 % |
|
| 2024-10-17 | -1.79 % |
|
| 2024-10-16 | +0.34 % |
|
| 2024-10-15 | +0.05 % |
|
| 2024-10-14 | +2.27 % |
|
| 2024-10-11 | -0.14 % |
|
| 2024-10-09 | -0.17 % |
|
| 2024-10-08 | +0.48 % |
|
| 2024-10-04 | +1.29 % |
|
| 2024-10-02 | -0.98 % |
|
| 2024-10-01 | -1.1 % |
|
| 2024-09-27 | +0.9 % |
|
| 2024-09-26 | +0.3 % |
|
| 2024-09-25 | -1.66 % |
|
| 2024-09-24 | -0.31 % |
|
| 2024-09-23 | +0.09 % |
|
| 2024-08-09 | +0.3 % |
- Hologic, Inc. (NASDAQ:HOLX) stock increased by 0.3% due to positive investor sentiment driven by the company's strong financial performance, its strategic acquisition of Endomagnetics, and its anticipated revenue growth despite post-pandemic challenges.
- Hologic Inc. (NASDAQ:HOLX) has reached a new 52-week high, with stock prices rising 0.3% to $84.37 due to strong financial results, investor confidence in its growth strategies, and a robust product pipeline, particularly in women's health and diagnostics. The stock goes up because of the company's solid revenue growth, positive guidance, strategic acquisitions, and shareholder-friendly practices like share buybacks.
|
| 2024-08-06 | +0.11 % |
|
| 2024-07-31 | -1.09 % |
|
| 2024-07-08 | +0.58 % |
|
| 2024-06-12 | -2.01 % |
|
| 2024-05-31 | +1.65 % |
|
| 2024-05-29 | -1.32 % |
|
| 2024-05-23 | -1.1 % |
|
| 2024-05-21 | -0.4 % |
|
| 2024-05-20 | -0.23 % |
|
